Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization

Andriy Yabluchanskiy1, Yonggang Ma1, Kristine Y DeLeon-Pennell1

  • 1Department of Physiology and Biophysics, San Antonio Cardiovascular Proteomics Center, Mississippi Center for Heart Research, University of Mississippi Medical Center, Jackson.

Insights

Matrix metalloproteinase-9 (MMP-9) deletion improved survival and attenuated age-related left ventricular remodeling after myocardial infarction. MMP-9 deficiency promoted anti-inflammatory macrophage responses, reducing cardiac dysfunction in aging mice.

Area of Science:

  • Cardiovascular Research
  • Aging Biology
  • Immunology

Background:

  • Aging exacerbates myocardial infarction (MI) consequences, leading to adverse left ventricular (LV) remodeling.
  • Matrix metalloproteinase-9 (MMP-9) plays a role in cardiac remodeling, but its specific contribution in aging post-MI is unclear.

Purpose of the Study:

  • To investigate the combined impact of aging and MI on LV remodeling.
  • To elucidate the role of MMP-9 in age-related cardiac dysfunction following MI.

Main Methods:

  • Utilized aged wild-type (WT) and MMP-9 Null (Null) mice (11-36 months) subjected to MI.
  • Assessed survival, LV dilation, inflammatory gene expression, and macrophage polarization at Day 7 post-MI.

Main Results:

  • MMP-9 deletion improved survival and attenuated age-dependent LV dilation post-MI.
  • WT mice showed age-dependent increases in pro-inflammatory genes, while Null mice exhibited altered inflammatory profiles and enhanced anti-inflammatory M2 macrophage markers.
  • MMP-9 deletion promoted M2 macrophage polarization without affecting M1 markers in the infarct zone.

Conclusions:

  • MMP-9 deletion mitigates adverse LV remodeling and dysfunction in aging post-MI hearts.
  • Targeting MMP-9 may offer a therapeutic strategy to improve outcomes in elderly patients after heart attack by modulating macrophage polarization.